US Patent 11072655 Markers of acute myeloid leukemia stem cells
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+223 characters)
Article
Patent abstract
Markers of acute myeloid leukemia stem cells (AMLSC) are identified. The markers are differentially expressed in comparison with normal counterpart cells, and are useful as diagnostic and therapeutic targets.
Edits on 11 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110726550
Date of Patent
July 27, 2021
0Patent Application Number
167389130
Date Filed
January 9, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
110726550
Date of Patent
July 27, 2021
0Patent Application Number
167389130
Date Filed
January 9, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 13 Feb, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11072655 Markers of acute myeloid leukemia stem cells
Infobox
Is a
Patent jurisdiction
Patent number
11072655
Date of patent
July 27, 2021
Patent application number
16738913
Date Filed
January 9, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 11072655 Markers of acute myeloid leukemia stem cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.